Musely Raises $360M Non-Dilutive Capital From General Catalyst; Hair Loss Telehealth Accelerates

Musely, a direct-to-consumer telehealth platform for dermatology, hair loss, and menopause, secured $360 million in non-dilutive capital from General Catalyst without selling equity. The milestone reflects surging consumer demand in telehealth for image-conscious indications.

FUNDRAISE

Editor

5/7/20261 min read

Musely closed a $360 million non-dilutive financing from General Catalyst, a rare structure that provides growth capital without diluting existing shareholders. Founder and CEO Jack Jia disclosed he was not actively fundraising when General Catalyst approached, suggesting strong organic momentum and investor conviction.

Musely delivers direct-to-consumer telehealth for dermatology, hair loss, and menopause care. The platform connects consumers with licensed practitioners remotely, bypassing traditional dermatology wait times and delivering prescriptions directly.

Hair loss is a substantial and growing segment within men's health, driven by social acceptance and willingness-to-pay for solutions. The platform's inclusion of this category alongside dermatology and menopause care reflects the durability of image-based health verticals in consumer telehealth.

The non-dilutive structure is strategically significant: it allows Musely to expand without ceding governance or diluting founder stakes, preserving optionality around profitability, IPO, or strategic exit. General Catalyst's conviction, backed by $360M, validates the unit economics and growth runway in consumer dermatology telehealth.